Find policies, billing codes, payers, states, and providers
CPT 52204: Cystourethroscopy with Biopsy
CPT code 52204 represents a cystourethroscopy with biopsy — an endoscopic diagnostic procedure used to inspect the urethra, prostatic urethra, bladder interior, and ureteric openings while obtaining tissue samples. This procedure is clinically important for diagnosing bladder and lower urinary tract conditions such as cystitis, hematuria, and suspicious lesions that require histologic evaluation. Because cystoscopy with biopsy directly informs diagnosis and subsequent management, reimbursement and coding practices for 52204 influence access to diagnostic evaluation across care settings.
Key national payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes coverage contexts and common billing considerations under these payers and highlights how 52204 is positioned relative to related cystoscopy and treatment codes.
Readers will learn the clinical scope and typical settings for 52204, common diagnostic indications, and the relationship between this code and related cystoscopy procedure codes. The report also provides operational context for billing staff and coding leads, including typical places of service and how 52204 differs from therapeutic cystoscopic procedures. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 52204 policy alerts
Get alerted when payer policies referencing 52204 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 52204 describes a diagnostic cystourethroscopy with biopsies performed through the cystoscope. The procedure involves inspection of the urethra, prostatic urethra (in men), the interior of the bladder, and the ureteric orifices using a cystoscope inserted through the urethra, with tissue biopsies taken through the instrument.
-
Service type: Endoscopic diagnostic procedure with biopsy
-
Typical site of service: Outpatient surgical suite, ambulatory surgery center, or hospital outpatient department
National Reimbursement Benchmarks
Medicare’s mean rate of $368.6 sits well below BUCA’s average commercial mean of $1,306.7, indicating a substantial gap between public reimbursement and this commercial benchmark. The difference of $938.1 highlights how commercial agreements with BUCA can yield materially higher average payments than Medicare for CPT 52204, which may influence payer mix economics and revenue expectations.
Dispersion varies notably across payers. Blue Cross Blue Shield shows the widest interquartile spread (P75–P25 = $2,891.0), followed by BUCA with a spread of $1,809.5 and UnitedHealth Group at $370.0, indicating broader variability in commercial contracting for those payers. Aetna and Cigna are comparatively tighter, with spreads of $289.0 and $335.0 respectively, signaling more consistent negotiated rates around their medians.